Teligent, Inc. To Present At Deutsche Bank 42nd Annual Health Care Conference On May 3, 2017

BUENA, N.J., May 3, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Deutsche Bank 42^nd Annual Health Care Conference. The Conference is taking place on May 3-4, 2017 at the InterContinental Boston Hotel, Boston, MA.

Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will present on Wednesday, May 3, 2017 at 12:50 p.m. ET. 

The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com.  A replay will be available for 30 days.  

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-present-at-deutsche-bank-42nd-annual-health-care-conference-on-may-3-2017-300450257.html

SOURCE Teligent, Inc.